Search research articles
Contact Us
Filters
Showing results (801-810 of 811) with videos related to
Page
of 82
Sort By:
Emerging Microbes & Infections
|
November 18, 2022
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
Hongqin Xu, Hongyan Li, Hailong You, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Fei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Neuro-Oncology Advances
|
May 29, 2026
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma
Guanzhang Li, Xiaoguang Qiu, Wei Zhang, et al.
Annals of Hematology
|
June 12, 2023
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
Jia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, et al.
Leukemia
|
March 11, 2020
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Si-Ye Chen, Yong Yang, Shu-Nan Qi, et al.
Nature Medicine
|
August 3, 2021
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
JAMA
|
November 28, 2023
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial
Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
The Lancet Regional Health. Western Pacific
|
March 7, 2023
Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study
Yuankai Shi, Xintian Qin, Xingchen Peng, et al.
Zhonghua Fu Chan Ke Za Zhi
|
March 3, 2010
[Epidemiological study of high risk human papillomavirus infection in 25 to 54 years old married women in Beijing.]
Ming-Hui Wu, Song-Wen Zhang, Wei-Yuan Zhang, et al.
Cancer Communications (London, England)
|
October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Ling-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
Page
of 82
Search research articles
Search
Showing results (801-810 of 811) with videos related to
Sort By:
Page
of 82
Emerging Microbes & Infections
|
November 18, 2022
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
Hongqin Xu, Hongyan Li, Hailong You, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Fei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Neuro-Oncology Advances
|
May 29, 2026
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma
Guanzhang Li, Xiaoguang Qiu, Wei Zhang, et al.
Annals of Hematology
|
June 12, 2023
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
Jia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, et al.
Leukemia
|
March 11, 2020
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Si-Ye Chen, Yong Yang, Shu-Nan Qi, et al.
Nature Medicine
|
August 3, 2021
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
JAMA
|
November 28, 2023
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial
Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, et al.
The Lancet Regional Health. Western Pacific
|
March 7, 2023
Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study
Yuankai Shi, Xintian Qin, Xingchen Peng, et al.
Zhonghua Fu Chan Ke Za Zhi
|
March 3, 2010
[Epidemiological study of high risk human papillomavirus infection in 25 to 54 years old married women in Beijing.]
Ming-Hui Wu, Song-Wen Zhang, Wei-Yuan Zhang, et al.
Cancer Communications (London, England)
|
October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Ling-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
Page
of 82